Looming dis-located IOL epidemic

Looming dis-located IOL epidemic
Arthur Cummings
Published: Monday, September 14, 2015

An increase in the rate of late intraocular lens dislocations occurring in Sweden and other countries may be partly due to the use of phacoemulsification in eyes in which extracapsular cataract surgery might be more appropriate, said Ulf Stenevi MD, Sweden, at the XXXII Congress of the ESCRS in Barcelona.

Dr Stenevi noted that 15 years ago late dislocations were uncommon enough to attract special interest when they occurred. But their rate of occurrence began to increase markedly starting around 2004.

As an example of the complications being encountered, he described the case of a man who had undergone uneventful phacoemulsification and eight years later had a dislocated IOL  in one eye and then a year later had a  dis-located IOL in the other eye.

He cited three studies carried out at different clinics in Sweden with extensive follow-up of large numbers of patients which indicate that the incidence appears to be around a half a per cent to one per cent of patients.

The studies also showed general agreement with other studies regarding the   risk factors for late IOL dislocation . The most important risk factor is pseudoexfoliation , others include concomitant eye disease, previous eye surgery, long axial length, and long phacoemulsification time.

He added that when he first presented his findings at the XXVI congress of the ESCRS in 2009, some were quick to christen the phenomena “the Swedish Syndrome”. However, they soon found that the rates of dislocations were rising in their own countries.

He suggested that the timing of the increased incidence of the late complication suggests that it is a delayed reaction to the adoption of phacoemulsification. He added that if current trends continue the number of patients affected annually will increase by 50 per cent.

 

 

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...